Atrial fibrillation prevalence revisited

The Net Clinical Benefit of Warfarin Anticoagulation in Atrial Fibrillation

(2013) Daniel E. Singer   ANNALS OF INTERNAL MEDICINE

Net Clinical Benefit of Warfarin in Patients With Atrial Fibrillation

(2012) Leif Friberg et al.   CIRCULATION

2012 focused update of the ESC Guidelines for the management of atrial fibrillation

(2012) et al.   EUROPACE

Assessment of female sex as a risk factor in atrial fibrillation in Sweden: nationwide retrospective cohort study

(2012) L. Friberg et al.   BMJ-British Medical Journal

External review and validation of the Swedish national inpatient register

(2011) Jonas F Ludvigsson et al.   BMC PUBLIC HEALTH

2011 ACCF/AHA/HRS Focused Updates Incorporated Into the ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation

(2011) Valentin Fuster et al.   CIRCULATION

Risks of thromboembolism and bleeding with thromboprophylaxis in patients with atrial fibrillation: A net clinical benefit analysis using a ‘real world’ nationwide cohort study

(2011) Gregory Lip et al.   THROMBOSIS AND HAEMOSTASIS

A Novel User-Friendly Score (HAS-BLED) To Assess 1-Year Risk of Major Bleeding in Patients With Atrial Fibrillation

(2010) Ron Pisters et al.   CHEST

Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach

(2009) Gregory Y.H. Lip et al.   CHEST

Stroke in paroxysmal atrial fibrillation: report from the Stockholm Cohort of Atrial Fibrillation

(2009) L. Friberg et al.   EUROPEAN HEART JOURNAL

Atrial fibrillation in the Malmö diet and cancer study: a study of occurrence, risk factors and diagnostic validity

(2009) J. Gustav Smith et al.   EUROPEAN JOURNAL OF EPIDEMIOLOGY